share_log
Benzinga ·  Jun 26 11:02
CNS Pharmaceuticala Shares Are Trading Lower After the Company Announced the Pricing of a Registered Direct Offering and Concurrent Private Placement of 568,000 Shares at $2.45 per Share
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment